Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Scientists harness light therapy to target and kill cancer c

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Sep 03, 2022 9:19am

179 Views

Post# 34939912

RE:Scientists harness light therapy to target and kill cancer c

Well, how about that? TLT has basically the same tech and it will be in FDA trials soon for solid tumors. Of course we could have AA for NMIBC in 6 months. I agree with the article that this is a 'breakthrough' Lol...

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland